The effects of acylation stimulating protein supplementation VS antibody neutralization on energy expenditure in wildtype mice

BMC Physiology

Volumn 10, Issue 1, 2010, Pages

  Paglialunga, Sabina ^a,b   Fisette, Alexandre ^a   Munkonda, Mercedes ^a   Gao, Ying ^a,c   Richard, Denis ^a   Cianflone, Katherine ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLATION STIMULATING PROTEIN, MOUSE; FATTY ACID; HORMONE; NEUTRALIZING ANTIBODY; RECOMBINANT PROTEIN; SIGNAL PEPTIDE;

ACYLATION; ADIPOCYTE; ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; C57BL MOUSE; CALORIMETRY; CELL STRAIN 3T3; COMPARATIVE STUDY; DRUG EFFECT; EATING; ENERGY METABOLISM; FAT INTAKE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOLOGY; INFUSION PUMP; MALE; METABOLISM; MOUSE; OXIDATION REDUCTION REACTION; PHYSIOLOGY;

3T3-L1 CELLS; ACYLATION; ADIPOCYTES; ANIMALS; ANTIBODIES, NEUTRALIZING; BLOOD GLUCOSE; BODY WEIGHT; CALORIMETRY, INDIRECT; DIETARY FATS; EATING; ENERGY METABOLISM; FATTY ACIDS, NONESTERIFIED; HORMONES; HUMANS; INFUSION PUMPS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED C57BL; OXIDATION-REDUCTION; RECOMBINANT PROTEINS;

EID: 77951137065     PISSN: None     EISSN: 14726793     Source Type: Journal    
DOI: 10.1186/1472-6793-10-4     Document Type: Article

References (32)

1. Critical review of Acylation Stimulating Protein physiology in humans and rodents. K Cianflone Z Xia LY Chen, Biochim Biophys Acta 2003 1609 127 143 10.1016/S0005-2736(02)00686-7 12543373
2. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Y Wu J Zhang Y Wen H Wang M Zhang K Cianflone, Fertil Steril 2009 91 213 219 10.1016/j.fertnstert.2007.11. 031 18206145
3. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. H Yu Y Yang M Zhang H Lu J Zhang H Wang, et al. Nutr Metab (Lond) 2006 3 13 10.1186/1743-7075-3-13 16472384
4. Lipoprotein lipase deficiency is associated with elevated acylation stimulating protein (ASP) plasma levels. S Paglialunga P Julien Y Tahiri F Cadelis J Bergeron D Gaudet, et al. J Lipid Res 2009 50 1109 1119 10.1194/jlr.M800430-JLR200 19237736
5. Effect of acylation stimulating protein on the triacylglycerol synthetic pathway of human adipose tissue. Z Yasruel K Cianflone AD Sniderman M Rosenbloom M Walsh MA Rodriguez, Lipids 1991 26 495 499 10.1007/BF02536592 1943492
6. ASP stimulates glucose transport in cultured human adipocytes. M Maslowska AD Sniderman R Germinario K Cianflone, Int J Obesity Rel Metab Dis 1997 21 261 266 10.1038/sj.ijo.0800396
7. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. M Faraj AD Sniderman K Cianflone, J Lipid Res 2004 45 657 666 10.1194/jlr.M300299-JLR200 14703506
8. Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin. V Van Harmelen S Reynisdottir K Cianflone E Degerman J Hoffstedt K Nilsell, et al. J Biol Chem 1999 274 18243 18251 10.1074/jbc.274.26.18243 10373426
9. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/Acylation-Stimulating Protein. D Kalant SA Cain M Maslowska AD Sniderman K Cianflone PN Monk, J Biol Chem 2003 278 11123 11129 10.1074/jbc.M206169200 12540846
10. C5L2 is a functional receptor for acylation stimulating protein. D Kalant R Maclaren W Cui R Samanta PN Monk SA Laporte, et al. J Biol Chem 2005 15833747
11. Acylation stimulating protein (ASP) deficiency alters postprandial and adipose tissue metabolism in male mice. I Murray AD Sniderman PJ Havel K Cianflone, J Biol Chem 1999 274 36219 36225 10.1074/jbc.274.51.36219 10593909
12. Shift in metabolic fuel in acylation-stimulating protein-deficient mice following a high-fat diet. C Roy S Paglialunga A Fisette P Schrauwen E Moonen-Kornips J St Onge, et al. Am J Physiol Endocrinol Metab 2008 294 1051 E1059 10.1152/ajpendo.00689.2007 18398012
13. Mice lacking acylation stimulating protein (ASP) have delayed postprandial triglyceride clearance. I Murray AD Sniderman K Cianflone, J Lipid Res 1999 40 1671 1676 10484614 (Pubitemid 29418708)
14. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. S Paglialunga A Fisette Y Yan Y Deshaies JF Brouillette M Pekna, et al. Am J Physiol Endocrinol Metab 2008 294 521 E529 10.1152/ajpendo.00590.2007 18160458
15. Acylation-stimulating Protein (ASP)/Complement C3adesArg Deficiency Results in Increased Energy Expenditure in Mice. Z Xia KL Stanhope E Digitale OM Simion L Chen P Havel, et al. J Biol Chem 2004 279 4051 4057 10.1074/jbc.M311319200 14615480
16. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. S Paglialunga P Schrauwen C Roy E Moonen-Kornips H Lu MK Hesselink, et al. J Endocrinol 2007 194 293 304 10.1677/JOE-07-0205 17641279
17. Acylation Stimulating Protein/C5L2 Neutralizing Antibodies alter Triglyceride Metabolism in vitro and in vivo. W Cui S Paglialunga D Kalant H Lu C Roy M Laplante, et al. Am J Physiol Endocrinol Metab 2007 293 6 1482 91 10.1152/ajpendo.00565.2006 17711993
18. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Saleh LKM Summers K Cianflone BA Fielding AD Sniderman KN Frayn, J Lipid Res 1998 39 884 891 9555951
19. Signal transduction pathway of acylation stimulating protein: Involvement of protein kinase C. A Baldo AD Sniderman S St Luce XJ Zhang K Cianflone, J Lipid Res 1995 36 1415 1426 7595065
20. Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytes. M Ho S Foxall M Higginbottom DM Donofrio J Liao PJ Richardson, et al. Metabolism 2006 55 8 12 10.1016/j.metabol.2005.06.013 16324913
21. Real-time quantification of fatty acid uptake using a novel fluorescence assay. J Liao R Sportsman J Harris A Stahl, J Lipid Res 2005 46 597 602 10.1194/jlr.D400023-JLR200 15547301
22. Effects of intracerebroventricular and intra-accumbens melanin-concentrating hormone agonism on food intake and energy expenditure. B Guesdon E Paradis P Samson D Richard, Am J Physiol Regul Integr Comp Physiol 2009 296 469 R475 19129377
23. Some mathematical and technical issues in the measurement and interpretation of open-circuit indirect calorimetry in small animals. JR Arch D Hislop SJ Wang JR Speakman, Int J Obes (Lond) 2006 30 1322 1331 10.1038/sj.ijo.0803280 16801931
24. Acute and sustained effects of isometric and lengthening muscle contractions on high-energy phosphates and glycogen metabolism in rat tibialis anterior muscle. MK Hesselink H Kuipers HA Keizer MR Drost GJ Van der Vusse, J Muscle Res Cell Motil 1998 19 373 380 10.1023/A:1005345603882 9635280
25. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. PJ Randle, Diabetes Metab Rev 1998 14 263 283 10.1002/(SICI)1099-0895(199812)14:4<263::AID-DMR2333.0.CO;2-C 10095997
26. Differential regulation of fatty acid trapping in mice adipose tissue and muscle by ASP. M Faraj K Cianflone, Am J Physiol 2004 287 150 E159
27. Coordinate regulation of triacylglycerol synthesis and glucose transport by Acylation Stimulating Protein. R Germinario AD Sniderman S Manuel S Pratt A Baldo K Cianflone, Metabolism 1993 42 574 580 10.1016/0026-0495(93)90215-A 8492712
28. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. SA Hawley M Davison A Woods SP Davies RK Beri D Carling, et al. J Biol Chem 1996 271 27879 27887 10.1074/jbc.271.44.27879 8910387
29. Identification of four novel human G protein-coupled receptors expressed in the brain. DK Lee SR George R Cheng T nguyen Y Liu M Brown, et al. Brain Res Mol Brain Res 2001 86 13 22 10.1016/S0169-328X(00)00242-4 11165367
30. Point: Interleukin-6 does have a beneficial role in insulin sensitivity and glucose homeostasis. BK Pedersen MA Febbraio, J Appl Physiol 2007 102 814 816 10.1152/japplphysiol.01208.2006 17068210
31. Counterpoint: Interleukin-6 does not have a beneficial role in insulin sensitivity and glucose homeostasis. RA Mooney, J Appl Physiol 2007 102 816 818 10.1152/japplphysiol.01208a.2006 17284655
32. Increased levels of acylation-stimulating protein in interleukin-6- deficient (IL-6(-/-)) mice. I Wernstedt B Olsson M Jernas S Paglialunga LM Carlsson U Smith, et al. Endocrinology 2006 147 2690 2695 10.1210/en.2005-1133 16513824